checkAd

     149  0 Kommentare Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence - Seite 3

    CONTACTS

    Company Contact:
    Erik Holmlin, CEO
    Bionano Genomics, Inc.
    +1 (858) 888-7610
    eholmlin@bionano.com

    Lesen Sie auch

    Investor Relations:
    David Holmes
    Gilmartin Group
    +1 (858) 888-7625
    IR@bionano.com


    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence - Seite 3 Bionano, a global leader in the transformation of the cytogenetic workflow with optical genome mapping (OGM), has entered into a strategic partnership with Hangzhou Diagens Biotechnology Co., Ltd. (Diagens), the pioneering leader in artificial …